Average Co-Inventor Count = 6.13
ph-index = 10
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Merck Frosst Canada, Inc. (9 from 212 patents)
2. Amgen Inc. (8 from 1,970 patents)
3. Merck Frosst Canada & Co. (6 from 76 patents)
4. Other (2 from 832,680 patents)
5. Syntex (u.s.a.) Inc. (2 from 932 patents)
6. Merck + Co., Inc. (1 from 4,770 patents)
7. Japan Tobacco Inc. (1 from 1,037 patents)
26 patents:
1. 8426358 - Methods for treating atherosclerosis
2. 7754890 - Arylsulfones and uses related thereto
3. 7635695 - Antiinflammation agents
4. 7402704 - Arylsulfones and uses related thereto
5. 7244727 - Fused bicyclic nitrogen-containing heterocycles
6. 7199119 - Antiinflammation agents
7. 7186841 - Antiinflammation agents
8. 7176314 - Inflammation modulators
9. 6846834 - Antiinflammation agents
10. 6627656 - Method of treatment using phenyl and biaryl derivatives as prostaglandin E inhibitors and compounds useful therefore
11. 6586457 - Methods for inhibiting bone resorption
12. 6436965 - PDE IV inhibiting amides, compositions and methods of treatment
13. 6410583 - Cyclopentanoindoles, compositions containing such compounds and methods of treatment
14. 6369082 - Carboxylic acids and acylsulfonamides, compositions containing such compounds and methods of treatment
15. 6369084 - Carboxylic acids and acylsulfonamides, compositions containing such compounds and methods of treatment